Skip Navigation

Cardiovascular Research 1998 40(2):396-401; doi:10.1016/S0008-6363(98)00177-1
© 1998 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Neunteufl, T.
Right arrow Articles by Stefenelli, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neunteufl, T.
Right arrow Articles by Stefenelli, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1998, European Society of Cardiology

Impairment of endothelium-independent vasodilation in patients with hypercalcemia

Thomas Neunteufl*, Reinhold Katzenschlager, Claudette Abela, Karam Kostner, Bruno Niederle, Franz Weidinger and Thomas Stefenelli

Departments of Cardiology, Vascular Medicine and Surgery, University of Vienna, Vienna, Austria

* Corresponding author. Tel.: +43-1-40400/4614; Fax: +43-1-408-1148.

Objective: Patients with primary hyperparathyroidism (PHPT) and/or hypercalcemia are at increased risk for myocardial ischemia. Whether PHPT is associated with altered endothelium-dependent dilation, vascular smooth muscle cell function, or both is unknown. This study was performed to test the hypothesis that endothelium-dependent, flow-mediated dilation (FMD) and/or endothelium-independent, nitroglycerin-induced dilation (NMD) is impaired in the preclinical phase of vascular disease in patients with PHPT. Methods: Twenty-six PHPT patients (mean±SD; age 55±15y, serum calcium 3.00±0.37 mmol/l, serum phosphate 0.79±0.21 mmol/l, iPTH 249±262 pg/ml) with no evidence of coronary artery disease (CAD) as well as 26 normocalcemic control subjects (CTL; age 51±12y) were studied. FMD following reactive hyperemia and NMD after 0.8 mg nitroglycerin (NTG) were assessed in the brachial artery by using high resolution ultrasound (7MHz). Results: NMD was impaired in PHPT patients compared to CTL (11.9±3.9% vs. 15.6±5.7%; p=0.012). FMD was similar in both study groups (11.6±4.6% vs. 12.6±4.9%; NS). The ratio of FMD to NMD was significantly different between PHPT patients and CTL (0.98±0.19 vs 0.81±0.25, p=0.009). On multiple stepwise regression analysis serum calcium was independently associated with the FMD/NMD ratio (r=0.34, p=0.017). Conclusions: Endothelium-independent vasodilation is impaired in PHPT patients without clinical evidence of coronary artery disease compared to normocalcemic CTL, while endothelium-dependent dilation was similar in both study groups. Thus, altered arterial reactivity in the course of PHPT may predominantly involve the arterial media and not the endothelium as observed previously in patients with various stages of atherosclerosis.

KEYWORDS Flow-mediated dilation; Nitroglycerin-induced vasodilation; Vascular disease; Hypercalcemia; Primary hyperparathyroidism; Ultrasound


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.